BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kho MML, Reinders MEJ, Baan CC, van Baarle D, Bemelman FJ, Diavatopoulos DA, Gansevoort RT, van der Klis FRM, Koopmans MPG, Messchendorp AL, van der Molen RG, Remmerswaal EBM, Rots N, Vart P, de Vries RD, Hilbrands LB, Sanders JF; RECOVAC Collaborators . The RECOVAC IR study: the immune response and safety of the mRNA-1273 COVID-19 vaccine in patients with chronic kidney disease, on dialysis, or living with a kidney transplant - a prospective, controlled, multicenter observational cohort by the REnal patients COVID-19 VACcination (RECOVAC) consortium COVID-19 VACcination (RECOVAC) consortium. Nephrol Dial Transplant 2021:gfab186. [PMID: 34038554 DOI: 10.1093/ndt/gfab186] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 10.5] [Reference Citation Analysis]
Number Citing Articles
1 Yang J, Lee KW, Baek JY, Bae S, Lee YH, Kim H, Huh K, Cho SY, Kang C, Chung DR, Peck KR, Park JB, Kim S, Kim T, Kim D, Ko J. Augmented humoral and cellular immunity against SARS-CoV-2 after breakthrough infection in kidney transplant recipients who received three doses of COVID-19 vaccine. American Journal of Transplantation 2023. [DOI: 10.1016/j.ajt.2022.12.022] [Reference Citation Analysis]
2 Spirito F, Mazzoccoli G, Di Cosola M, Lo Muzio L. Solid organ transplantation and SARS-CoV-2 vaccines: is there a possible alternative? Gazz Med Ital - Arch Sci Med 2022;181. [DOI: 10.23736/s0393-3660.22.04907-5] [Reference Citation Analysis]
3 Imhof C, Messchendorp AL, van der Heiden M, Baan CC, van der Molen RG, Remmerswaal EBM, de Vries RD, Diavatopoulos DA, Boerma A, Bakker FJ, Oosterhout E, Bemelman FJ, Hilbrands LB, Reinders MEJ, Gansevoort RT, Sanders JS, van Baarle D. SARS-CoV-2 Spike-specific IFN-γ T-cell Response After COVID-19 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney Transplant. Transplant Direct 2022;8:e1387. [PMID: 36284929 DOI: 10.1097/TXD.0000000000001387] [Reference Citation Analysis]
4 Frölke SC, Bouwmans P, Messchendorp AL, Geerlings SE, Hemmelder MH, Gansevoort RT, Hilbrands LB, Reinders ME, Sanders JF, Bemelman FJ, Peters-sengers H; RECOVAC Collaborators. Predictors of Nonseroconversion to SARS-CoV-2 Vaccination in Kidney Transplant Recipients. Transplantation Direct 2022;8:e1397. [DOI: 10.1097/txd.0000000000001397] [Reference Citation Analysis]
5 Yang IN, Lu CL, Tang HJ, Kuo YC, Tsai LH, Tu KC, Wang JJ, Chien CC. Safety of ChAdOx1 nCoV-19 vaccination in patients with end-stage renal disease on hemodialysis. PLoS One 2022;17:e0273676. [PMID: 36084024 DOI: 10.1371/journal.pone.0273676] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Halfon M, Stavart L, Venetz J, Manuel O, Golshayan D. Kidney Transplantation in Patients With Active SARS-CoV-2 Replication: An Initial Case Series. Transpl Int 2022;35:10716. [DOI: 10.3389/ti.2022.10716] [Reference Citation Analysis]
7 Sáez-Peñataro J, Torres F, Bartra J, Bascuas J, Vilella A, Tortajada M, Quesada S, González E, López-Suñé E, Castells A, Serrano S, Camacho C, Trilla A, Calvo G; VigilVacCOVID Group. Tolerability and Reactogenicity Profile of mRNA SARS-Cov-2 Vaccines from a Mass Vaccination Campaign in a Tertiary Hospital: Between-Vaccine and Between-Population Prospective Observational Study (VigilVacCOVID Study). BioDrugs 2022. [PMID: 35764768 DOI: 10.1007/s40259-022-00543-9] [Reference Citation Analysis]
8 Herman-Edelstein M, Ben-Dor N, Agur T, Guetta T, Raiter A, Meisel E, Alkeesh W, Ori Y, Rozen-Zvi B, Zingerman B. BNT162b2 Booster Vaccination Induced Immunity against SARS-CoV-2 Variants among Hemodialysis Patients. Vaccines (Basel) 2022;10:967. [PMID: 35746575 DOI: 10.3390/vaccines10060967] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
9 Liu C, Lee J, Ta C, Soroush A, Rogers J, Kim JH, Natarajan K, Zucker J, Perl Y, Weng C. A Retrospective Analysis of Risk Factors Associated with the SARS-CoV-2 Breakthrough in Fully mRNA Vaccinated Individuals. JMIR Public Health Surveill 2022. [PMID: 35486806 DOI: 10.2196/35311] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
10 Haggenburg S, Hofsink Q, Lissenberg-witte BI, Broers AE, van Doesum JA, van Binnendijk RS, Hartog GD, Bhoekhan MS, Haverkate NJ, Burger JA, Bouhuijs JH, Smits GP, Wouters D, van Leeuwen EM, Bontkes HJ, Kootstra NA, Zweegman S, Kater AP, Heemskerk MH, Groen K, van Meerten T, Mutsaers PG, Beaumont T, van Gils MJ, Goorhuis A, Rutten CE, Hazenberg MD, Nijhof IS. Three-dose mRNA-1273 vaccination schedule: sufficient antibody response in majority of immunocompromised hematology patients.. [DOI: 10.1101/2022.04.08.22273602] [Reference Citation Analysis]
11 Cuadrado A, Del Barrio M, Fortea JI, Amigo L, San Segundo D, Rodriguez-Cundin MP, Rebollo MH, Fernandez-Santiago R, Castillo F, Achalandabaso M, Echeverri J, Anderson EJ, Rodríguez-Sanjuan JC, López-Hoyos M, Crespo J, Fábrega E. Antibody response to the messenger RNA-1273 vaccine (Moderna) in liver transplant recipients. Hepatol Commun 2022. [PMID: 35344281 DOI: 10.1002/hep4.1937] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
12 Berar-Yanay N, Freiman S, Shapira M, Saffoury A, Elemy A, Hamze M, Elhaj M, Zaher M, Matanis L, Armaly ZA. Waning Humoral Response 3 to 6 Months after Vaccination with the SARS-COV-2 BNT162b2 mRNA Vaccine in Dialysis Patients. J Clin Med 2021;11:64. [PMID: 35011801 DOI: 10.3390/jcm11010064] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
13 Affeldt P, Koehler FC, Brensing KA, Adam V, Burian J, Butt L, Gies M, Grundmann F, Hinrichs S, Johannis W, Kalisch N, Meyer-Delpho M, Oehm S, Platen E, Schöler C, Heger E, Steger G, Stippel D, Ziegelhöfer A, Benzing T, Klein F, Kurschat C, Müller RU, Cristanziano VD. Immune Responses to SARS-CoV-2 Infection and Vaccination in Dialysis Patients and Kidney Transplant Recipients. Microorganisms 2021;10:4. [PMID: 35056453 DOI: 10.3390/microorganisms10010004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
14 Liu C, Lee J, Ta C, Soroush A, Rogers JR, Kim JH, Natarajan K, Zucker J, Perl Y, Weng C. Risk Factors Associated With SARS-CoV-2 Breakthrough Infections in Fully mRNA-Vaccinated Individuals: Retrospective Analysis (Preprint).. [DOI: 10.2196/preprints.35311] [Reference Citation Analysis]
15 Mckarns SC. Did Science Leadership Fail SARS-CoV-2 Vaccination Acceptance? IJIER 2021;9:39-47. [DOI: 10.31686/ijier.vol9.iss12.3535] [Reference Citation Analysis]
16 Fernández-Ruiz M, Almendro-Vázquez P, Carretero O, Ruiz-Merlo T, Laguna-Goya R, San Juan R, López-Medrano F, García-Ríos E, Más V, Moreno-Batenero M, Loinaz C, Andrés A, Pérez-Romero P, Paz-Artal E, Aguado JM. Discordance Between SARS-CoV-2-specific Cell-mediated and Antibody Responses Elicited by mRNA-1273 Vaccine in Kidney and Liver Transplant Recipients. Transplant Direct 2021;7:e794. [PMID: 34805496 DOI: 10.1097/TXD.0000000000001246] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 6.5] [Reference Citation Analysis]
17 Liu C, Lee J, Ta C, Soroush A, Rogers JR, Kim JH, Natarajan K, Zucker J, Weng C. A Retrospective Analysis of COVID-19 mRNA Vaccine Breakthrough Infections - Risk Factors and Vaccine Effectiveness. medRxiv 2021:2021. [PMID: 34642696 DOI: 10.1101/2021.10.05.21264583] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 11.0] [Reference Citation Analysis]
18 Swai J, Gui M, Long M, Wei Z, Hu Z, Liu S. Humoral and cellular immune response to severe acute respiratory syndrome coronavirus-2 vaccination in haemodialysis and kidney transplant patients. Nephrology (Carlton) 2021. [PMID: 34510645 DOI: 10.1111/nep.13974] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
19 Yen CC, Lin SY, Chen SC, Chiu YW, Chang JM, Hwang SJ. COVID-19 Vaccines in Patients with Maintenance Hemodialysis. J Pers Med 2021;11:789. [PMID: 34442432 DOI: 10.3390/jpm11080789] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
20 Carr EJ, Kronbichler A, Graham-Brown M, Abra G, Argyropoulos C, Harper L, Lerma EV, Suri RS, Topf J, Willicombe M, Hiremath S. Review of Early Immune Response to SARS-CoV-2 Vaccination Among Patients With CKD. Kidney Int Rep 2021;6:2292-304. [PMID: 34250319 DOI: 10.1016/j.ekir.2021.06.027] [Cited by in Crossref: 60] [Cited by in F6Publishing: 64] [Article Influence: 30.0] [Reference Citation Analysis]